Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS Negl Trop Dis ; 3(11): e544, 2009 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-19901988

RESUMEN

Human onchocerciasis, caused by the filarial nematode Onchocerca volvulus, is controlled almost exclusively by the drug ivermectin, which prevents pathology by targeting the microfilariae. However, this reliance on a single control tool has led to interest in vaccination as a potentially complementary strategy. Here, we describe the results of a trial in West Africa to evaluate a multivalent, subunit vaccine for onchocerciasis in the naturally evolved host-parasite relationship of Onchocerca ochengi in cattle. Naïve calves, reared in fly-proof accommodation, were immunised with eight recombinant antigens of O. ochengi, administered separately with either Freund's adjuvant or alum. The selected antigens were orthologues of O. volvulus recombinant proteins that had previously been shown to confer protection against filarial larvae in rodent models and, in some cases, were recognised by serum antibodies from putatively immune humans. The vaccine was highly immunogenic, eliciting a mixed IgG isotype response. Four weeks after the final immunisation, vaccinated and adjuvant-treated control calves were exposed to natural parasite transmission by the blackfly vectors in an area of Cameroon hyperendemic for O. ochengi. After 22 months, all the control animals had patent infections (i.e., microfilaridermia), compared with only 58% of vaccinated cattle (P = 0.015). This study indicates that vaccination to prevent patent infection may be an achievable goal in onchocerciasis, reducing both the pathology and transmissibility of the infection. The cattle model has also demonstrated its utility for preclinical vaccine discovery, although much research will be required to achieve the requisite target product profile of a clinical candidate.


Asunto(s)
Antígenos Helmínticos/administración & dosificación , Bovinos , Modelos Animales de Enfermedad , Onchocerca/inmunología , Oncocercosis/prevención & control , Vacunas/administración & dosificación , Animales , Anticuerpos Antihelmínticos/sangre , Anticuerpos Antihelmínticos/inmunología , Antígenos Helmínticos/genética , Antígenos Helmínticos/inmunología , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Masculino , Oncocercosis/sangre , Oncocercosis/inmunología , Oncocercosis/parasitología , Simuliidae , Vacunación , Vacunas/genética , Vacunas/inmunología
2.
J Wildl Dis ; 45(2): 542-6, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19395769

RESUMEN

New methods are required to increase our understanding of pathologic processes in wild mammals. We developed a noninvasive field method to estimate the body temperature of wild living chimpanzees habituated to humans, based on statistically fitting temperature decline of feces after defecation. The method was established with the use of control measures of human rectal temperature and subsequent changes in fecal temperature over time. The method was then applied to temperature data collected from wild chimpanzee feces. In humans, we found good correspondence between the temperature estimated by the method and the actual rectal temperature that was measured (maximum deviation 0.22 C). The method was successfully applied and the average estimated temperature of the chimpanzees was 37.2 C. This simple-to-use field method reliably estimates the body temperature of wild chimpanzees and probably also other large mammals.


Asunto(s)
Enfermedades del Simio Antropoideo/diagnóstico , Temperatura Corporal/fisiología , Heces , Pan troglodytes/fisiología , Animales , Animales Salvajes , Sensibilidad y Especificidad , Vigilancia de Guardia/veterinaria
3.
J Virol ; 82(15): 7741-4, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18508895

RESUMEN

Simian foamy viruses (SFV) are ancient retroviruses of primates and have coevolved with their host species for as many as 30 million years. Although humans are not naturally infected with foamy virus, infection is occasionally acquired through interspecies transmission from nonhuman primates. We show that interspecies transmissions occur in a natural hunter-prey system, i.e., between wild chimpanzees and colobus monkeys, both of which harbor their own species-specific strains of SFV. Chimpanzees infected with chimpanzee SFV strains were shown to be coinfected with SFV from colobus monkeys, indicating that apes are susceptible to SFV superinfection, including highly divergent strains from other primate species.


Asunto(s)
Colobus/virología , Pan troglodytes/virología , Infecciones por Retroviridae/transmisión , Virus Espumoso de los Simios/aislamiento & purificación , Animales , Côte d'Ivoire , Femenino , Masculino , Datos de Secuencia Molecular , Filogenia , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico , Virus Espumoso de los Simios/fisiología , Proteínas Virales/genética
4.
Proc Natl Acad Sci U S A ; 103(15): 5971-6, 2006 Apr 11.
Artículo en Inglés | MEDLINE | ID: mdl-16585501

RESUMEN

Onchocerciasis (river blindness) is a major parasitic disease of humans in sub-Saharan Africa caused by the microfilarial stage of the nematode Onchocerca volvulus. Using Onchocerca ochengi, a closely related species which infects cattle and is transmitted by the same black fly vector (Simulium damnosum sensu lato) as O. volvulus, we have conducted longitudinal studies after either natural field exposure or experimental infection to determine whether, and under what circumstances, protective immunity exists in onchocerciasis. On the basis of the adult worm burdens (nodules) observed, we determined that cattle reared in endemic areas without detectable parasites (putatively immune) were significantly less susceptible to heavy field challenge than age-matched, naïve controls (P = 0.002), whereas patently infected cattle, cured of infection by adulticide treatment with melarsomine, were fully susceptible. Cattle immunized with irradiated third-stage larvae were significantly protected against experimental challenge (100% reduction in median nodule load, P = 0.003), and vaccination also conferred resistance to severe and prolonged field challenge (64% reduction in median nodule load, P = 0.053; and a significant reduction in microfilarial positivity rates and density, P < 0.05). These results constitute evidence of protective immunity in a naturally evolved host-Onchocerca sp. relationship and provide proof-of-principle for immunoprophylaxis under experimental and field conditions.


Asunto(s)
Oncocercosis/inmunología , Oncocercosis/veterinaria , Vacunas , Animales , Antihelmínticos/uso terapéutico , Bovinos , Enfermedades de los Bovinos/tratamiento farmacológico , Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/inmunología , Modelos Animales de Enfermedad , Onchocerca , Oncocercosis/tratamiento farmacológico , Oncocercosis/epidemiología , Prevalencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA